Document › Details
Accovion GmbH. (12/1/14). "Press Release: Accovion Launches New Subsidiary in France". Frankfurt & Eschborn.
|Organisation 2||Accovion GmbH|
|Product||contract research (drugs)|
|Product 2||clinical research services|
|Person||Waller, Ivana (Accovion 201010 COO)|
|Person 2||Humbey, Olivier (Accovion 201412– Country Director France)|
Accovion announces the establishement of a new subsidiary in Lyon, France, as it continues its expansion across Europe
Accovion, a leading independent European full-service Contract Research Organization, headquartered in Frankfurt (Eschborn), Germany, announced today the establishement of a new subsidiary in Lyon, France, as it continues its expansion across Europe. Together with offices in Italy, Poland, Russia, Romania, Spain, Czech Republic and United Kingdom, Accovion is now able to present itself with eight subsidiaries and overall coverage of 20 European countries.
Ivana Waller, the COO of Accovion Group states: “France represents a key strategic territory in terms of conducting clinical trials in Europe and therefore the new French subsidiary reinforces our mission to better serve our clients by offering a broader European footprint. The rationale for setting up the company specifically in Lyon is based on the fact that this region has a high concentration of pharmaceutical and biotech companies, as well as various related support companies engaged in the field of life sciences. This provides us with proximity to our clients, access to experienced talent pool, abundant clinical research sites as well as access to key opinion leaders.” She adds: “The city of Lyon provides an active support to the life sciences companies, including many networking opportunities and rigorous support and promotion of the local Bio-cluster. In addition, the city is generally business friendly and progressive.”
The local entity will be headed by Dr. Olivier Humbey, who was appointed Country Director, France on 1 November 2014. Dr. Humbey, French native, will be spearheading not only the company’s activities in France, but given his extensive scientific background, well-networked position in the industry and abundant experience, strongly support the strategies of the entire Accovion Group.
“It is with a tremendous pleasure that I am joining the Accovion Group and its growing international team. I look very much forward to bringing my experience in the clinical research field to pursue Accovion’s successful development and build on its excellent reputation for the best of our clients’ developments. Together we will ensure that our French operations are integrating the recognized quality services provided by Accovion on the EU market”, emphasizes Dr. Humbey with regard to his new responsibilities.
Record changed: 2017-04-02
More documents for Clinipace (Group)
-  Accovion GmbH. (4/13/15). "Press Release: Accovion Signs Agreement to Be Acquired by Clinipace Worldwide". Frankfurt & Eschborn....
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to email@example.com and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)